Kwangdong Healthbio holds investor relations briefing at Korea Exchange conference hall

• Kwangdong Healthbio held an investor relations briefing at the Korea Exchange in Seoul on Oct. 6, 2026.
• The session ran 13:30–15:10 local time, featuring a company overview, an update on key management matters, Q&A.
• Attendees included analysts, institutional investors, angel investors, venture capital investors active in the KONEX market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kwangdong Healthbio Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006600346), on October 06, 2026, and is solely responsible for the information contained therein.